Twelve‐month outcomes following temperature‐controlled radiofrequency treatment of the septal swell body for nasal airway obstruction

Jordan Pritikin,Stacey Silvers,Jeffrey Rosenbloom,Bryan Davis,Anthony Del Signore,Ahmad R. Sedaghat,Bobby A. Tajudeen,Isaac Schmale,Rakesh Chandra
DOI: https://doi.org/10.1002/alr.23383
2024-06-07
International Forum of Allergy & Rhinology
Abstract:Background Improved nasal airway obstruction (NAO) symptoms were reported at 3 months following temperature‐controlled radiofrequency (TCRF) treatment of the septal swell body (SSB). This report provides results from assessments of the long‐term safety and efficacy of TCRF treatment of SSB hypertrophy to treat NAO through 12 months posttreatment. Methods This prospective, multicenter, long‐term, open‐label study was conducted in nine centers within the United States and included patients with severe/extreme NAO attributed to SSB hypertrophy. Outcome measures included assessments of Nasal Obstruction Symptom Evaluation Score (NOSE), Numeric Rating Scale (NRS) ease‐of‐breathing, patient satisfaction, and adverse events at 6 and 12 months. Results Of the 70 patients treated, 65 and 62 patients completed the 6‐ and 12‐month follow‐up assessments. Compared to baseline, there was a 67.5% decrease in adjusted mean NOSE scores at 6 months (mean change −49.6, 95% confidence interval [CI] −54.8 to −44.4; p
otorhinolaryngology
What problem does this paper attempt to address?